Cyclophosphamide trials for Systemic Sclerosis

All Cyclophosphamide trials · All Systemic Sclerosis trials

Phase breakdown

Recruiting trials studying Cyclophosphamide for Systemic Sclerosis

• A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
  NCT06733935 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 18 locations
• A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
  NCT07085104 · Phase: Phase 1 · Ages: 18 Years to 74 Years · Sex: All (male and female) · 17 locations
• Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
  NCT03630211 · Phase: Phase 2 · Ages: 8 Years to 60 Years · Sex: All (male and female) · 3 locations
• Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
  NCT06434363 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials study Cyclophosphamide for Systemic Sclerosis?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.